Search

Author/Creator Stadler, Walter M.

1. A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma. (May 2014)

Authors:
Pond, Gregory R.; Agarwal, Neeraj; Bellmunt, Joaquim; Choueiri, Toni K.; Qu, Angela; Fougeray, Ronan; Vaughn, David; James, Nicholas D.; Salhi, Yacine; Albers, Peter; Niegisch, Günter; Galsky, Matthew D.; Wong, Yu‐Ning; Ko, Yoo‐Joung; Stadler, Walter M.; O'Donnell, Peter H.; Sridhar, Srikala S.; ...
Journal:
BJU international
Issue:
Volume 113:Number 5b(2014:May)
Page Start:
E137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. Issue 11 (27th February 2014)

Authors:
Garcia, Jorge A.; Hudes, Gary R.; Choueiri, Toni K.; Stadler, Walter M.; Wood, Laura S.; Gurtler, Jayne; Bhatia, Shailender; Joshi, Adarsh; Hozak, Rebecca R.; Xu, Yihuan; Schwartz, Jonathan D.; Thompson, John A.
Journal:
Cancer
Issue:
Volume 120:Issue 11(2014)
Page Start:
1647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. Issue 11 (27th February 2014)

Authors:
Garcia, Jorge A.; Hudes, Gary R.; Choueiri, Toni K.; Stadler, Walter M.; Wood, Laura S.; Gurtler, Jayne; Bhatia, Shailender; Joshi, Adarsh; Hozak, Rebecca R.; Xu, Yihuan; Schwartz, Jonathan D.; Thompson, John A.
Journal:
Cancer
Issue:
Volume 120:Issue 11(2014)
Page Start:
1647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Issue 10 (19th February 2020)

Authors:
Kochanny, Sara E.; Worden, Francis P.; Adkins, Douglas R.; Lim, Dean W.; Bauman, Julie E.; Wagner, Stephanie A.; Brisson, Ryan J.; Karrison, Theodore G.; Stadler, Walter M.; Vokes, Everett E.; Seiwert, Tanguy Y.
Journal:
Cancer
Issue:
Volume 126:Issue 10(2020)
Page Start:
2146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study. Issue 14 (4th May 2020)

Authors:
Seiwert, Tanguy Y.; Kochanny, Sara; Wood, Kevin; Worden, Francis P.; Adkins, Douglas; Wade, James L.; Sleckman, Bethany G.; Anderson, Daniel; Brisson, Ryan J.; Karrison, Theodore; Stadler, Walter M.; Vokes, Everett E.
Journal:
Cancer
Issue:
Volume 126:Issue 14(2020)
Page Start:
3237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC). Issue 13 (25th March 2021)

Authors:
Harrison, Michael R.; Costello, Brian A.; Bhavsar, Nrupen A.; Vaishampayan, Ulka; Pal, Sumanta K.; Zakharia, Yousef; Jim, Heather S. L.; Fishman, Mayer N.; Molina, Ana M.; Kyriakopoulos, Christos E.; Tsao, Che‐Kai; Appleman, Leonard J.; Gartrell, Benjamin A.; Hussain, Arif; Stadler, Walter M.; Ag...
Journal:
Cancer
Issue:
Volume 127:Issue 13(2021)
Page Start:
2204
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer. Issue 7 (11th December 2013)

Authors:
Stadler, Walter M.; Vaughn, David J.; Sonpavde, Guru; Vogelzang, Nicholas J.; Tagawa, Scott T.; Petrylak, Daniel P.; Rosen, Peter; Lin, Chia‐Chi; Mahoney, John; Modi, Sanjiv; Lee, Peter; Ernstoff, Marc S.; Su, Wu‐Chou; Spira, Alexander; Pilz, Korinna; Vinisko, Richard; Schloss, Charles; Fritsch, ...
Journal:
Cancer
Issue:
Volume 120:Issue 7(2014)
Page Start:
976
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer. Issue 7 (11th December 2013)

Authors:
Stadler, Walter M.; Vaughn, David J.; Sonpavde, Guru; Vogelzang, Nicholas J.; Tagawa, Scott T.; Petrylak, Daniel P.; Rosen, Peter; Lin, Chia‐Chi; Mahoney, John; Modi, Sanjiv; Lee, Peter; Ernstoff, Marc S.; Su, Wu‐Chou; Spira, Alexander; Pilz, Korinna; Vinisko, Richard; Schloss, Charles; Fritsch, ...
Journal:
Cancer
Issue:
Volume 120:Issue 7(2014)
Page Start:
976
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Axitinib in Metastatic Renal Cell Carcinoma: Results of a Pharmacokinetic and Pharmacodynamic Analysis. (28th March 2013)

Authors:
Rini, Brian I.; Garrett, May; Poland, Bill; Dutcher, Janice P.; Rixe, Olivier; Wilding, George; Stadler, Walter M.; Pithavala, Yazdi K.; Kim, Sinil; Tarazi, Jamal; Motzer, Robert J.
Journal:
Journal of clinical pharmacology
Issue:
Volume 53:Number 5(2013:May)
Page Start:
491
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗